○Takashi Ashino¹, Yuki Nakamura¹, Hirokazu Ohtaki², Yoichiro Iwakura³, Satoshi Numazawa¹ (1. Sch. Pharm., Showa Univ., 2. Sch. Med., Showa Univ., 3. Res. Inst. Biomed. Sci., Tokyo Univ. Sci.)

○Tomokazu Ohnuma¹, Yuika Takeda¹, Takahito Nishiyama¹, Kenichiro Ogura¹, Akira Hiratsuka¹ (1. School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

○Takahito Nishiyama¹, Yasuhiro Kawamori¹, Momoka Tadokoro¹, Tomomi Kitagawa¹, Tomokazu Ohunma¹, Kenichiro Ogura¹, Satoshi Yamaori¹ (1. Department of Drug Metabolism and Molecular Toxicology, School of Pharmacy, Tokyo University of Pharmacy and Life Sciences)

○Kenichiro Ogura¹, Teruyuki Ishikawa¹, Saori Kato¹, Yuika Sanada¹, Tomokazu Ohnuma¹, Takahito Nishiyama¹, Satoshi Yamaori¹ (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)

○Shiori Takano¹, Tatsuki Fukami^1,2, Hiroyuki Ichida¹, Kohei Suzuki¹, Masataka Nakano^1,2, Miki Nakajima^1,2 (1. Institute of Medical, Pharmaceutical and Health Sciences, Faculty of Pharmacy, Kanazawa Univ., 2. Nano Life Science Institute)

○Katsunobu Utsumi¹, Seigo Sanoh^1,2, Naoki Takaoka^1,2, Kazumi Sugihara³, Yaichiro Kotake¹ (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Sch. Pharm. Sci, Wakayama Med. Univ., 3. Hiroshima International Univ.)

○Risa Okon¹, Mana Yamaguchi¹, Miyu Nishikawa¹, Shinichi Ikushiro¹, Toshiyuki Sakaki¹, Kaori Yasuda¹ (1. Grad. Sch. Eng., Toyama Pref. Univ.)

Yusuke Kamiya¹, Tasuku Sato ¹, Saho Morikuni ¹, Masayoshi Utsumi¹, Tomonori Miura ¹, Norie Murayama ¹, Makiko Shimizu ¹, Kentaro Handa ², Masato Kitajima², Fumiaki Shono³, ○Hiroshi Yamazaki¹ (1. Showa Pharma Univ, 2. Fujitsu, 3. Nara Institute of Sci Tech)

○Norie Murayama¹, Yutaro Noda¹, Shiori Jikuya², Yasuhiro Uno², Hiroshi Yamazaki ¹ (1. Showa Pharma. Univ., 2. Kagoshima Univ., Vet Med.)

○Makiko Shimizu¹, Miaki Makiguchi¹, Yuria Nakamura¹, Eiji Hishinuma^2,3, Sakae Saito^2,3, Masahiro Hiratsuka^2,3,4, Hiroshi Yamazaki¹ (1. Showa Pharma Univ, 2. INGEM, Tohoku Univ, 3. ToMMo, Tohoku Univ, 4. Grad Sch Pharm Sci, Tohoku Univ)